Urinary tract infections (UTIs) can be a serious medical condition, sometimes becoming life-threatening, and may be especially concerning for older adults who have coexisting health conditions. UTIs may occur for a variety of reasons, including as a symptom of menopause or separate from the menopausal process. Crucially, vaginal estrogen can help prevent recurring UTIs among older women, alleviate other menopausal symptoms, and may be used by a broad range of patients.
 
As of 2025, the American Urological Association guidelines for clinicians now recommend that perimenopausal and postmenopausal women with recurrent UTIs, receive vaginal estrogen therapy to reduce the risk of future UTIs, so long as vaginal estrogen therapy is not otherwise contraindicated.[1]
 
For those reasons, I plan to introduce legislation to require insurance coverage for vaginal estrogen to treat menopausal symptoms and as a preventative measure for recurring UTIs. My bill will ensure that our older adults are able to use vaginal estrogen and receive the full range of benefits that it may provide, while also reducing the financial burden that often occurs with frequent UTI treatment.
 
Please join me in co-sponsoring this legislation to make an important medical tool more accessible.